JNJ Press releases
News
JNJ Press releases
EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Memorandum of Understanding with Kyoto University to Collaborate in Identifying and Accelerating the Development of Innovative Healthcare Solutions
Read full storyJNJ Press releases
Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Finalists of Cognition Challenge
Read full storyJNJ Press releases